Listed

XTL Biopharmaceuticals Ltd

XTLBNasdaqCIK 1023549Healthcare

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalents$371.0k, FY2024
Shareholders' equity$5.4m, FY2024
Line itemUnitperiod not labelled2014-12-31period not labelled2015-12-31period not labelled2016-12-31FY20172017-12-31FY20182018-12-31FY20192019-12-31FY20202020-12-31FY20212021-12-31FY20222022-12-31period not labelled2023-12-31period not labelled2024-08-14FY20242024-12-31
Cash and equivalents$k2,159Cash and equivalents, period not labelled, at 2014-12-31$2.2m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2018-03-15, accession 0001213900-18-003028.Report this figure3,817Cash and equivalents, period not labelled, at 2015-12-31$3.8m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2019-03-11, accession 0001213900-19-003911.Report this figure2,019Cash and equivalents, period not labelled, at 2016-12-31$2.0m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2020-03-12, accession 0001213900-20-006104.Report this figure3,289Cash and equivalents, FY2017, at 2017-12-31$3.3m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F/A filed 2021-05-19, accession 0001213900-21-027792.Report this figure3,255Cash and equivalents, FY2018, at 2018-12-31$3.3m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2022-03-30, accession 0001213900-22-016244.Report this figure4,455Cash and equivalents, FY2019, at 2019-12-31$4.5m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2023-03-22, accession 0001213900-23-021869.Report this figure3,631Cash and equivalents, FY2020, at 2020-12-31$3.6m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2023-03-22, accession 0001213900-23-021869.Report this figure2,969Cash and equivalents, FY2021, at 2021-12-31$3.0m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figure2,094Cash and equivalents, FY2022, at 2022-12-31$2.1m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figure1,401Cash and equivalents, period not labelled, at 2023-12-31$1.4m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figurenot reported371Cash and equivalents, FY2024, at 2024-12-31$371.0k. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figure
Current assets$knot reportednot reported2,754Current assets, period not labelled, at 2016-12-31$2.8m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2018-03-15, accession 0001213900-18-003028.Report this figure6,206Current assets, FY2017, at 2017-12-31$6.2m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2019-03-11, accession 0001213900-19-003911.Report this figure8,195Current assets, FY2018, at 2018-12-31$8.2m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2020-03-12, accession 0001213900-20-006104.Report this figure6,830Current assets, FY2019, at 2019-12-31$6.8m. XBRL concept ifrs-full:CurrentAssets. 20-F/A filed 2021-05-19, accession 0001213900-21-027792.Report this figure6,121Current assets, FY2020, at 2020-12-31$6.1m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2022-03-30, accession 0001213900-22-016244.Report this figure6,237Current assets, FY2021, at 2021-12-31$6.2m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2023-03-22, accession 0001213900-23-021869.Report this figure3,806Current assets, FY2022, at 2022-12-31$3.8m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2023-03-22, accession 0001213900-23-021869.Report this figure2,046Current assets, period not labelled, at 2023-12-31$2.0m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figurenot reported1,340Current assets, FY2024, at 2024-12-31$1.3m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figure
Total assets$knot reportednot reported3,017Total assets, period not labelled, at 2016-12-31$3.0m. XBRL concept ifrs-full:Assets. 20-F filed 2018-03-15, accession 0001213900-18-003028.Report this figure6,586Total assets, FY2017, at 2017-12-31$6.6m. XBRL concept ifrs-full:Assets. 20-F filed 2019-03-11, accession 0001213900-19-003911.Report this figure8,575Total assets, FY2018, at 2018-12-31$8.6m. XBRL concept ifrs-full:Assets. 20-F filed 2020-03-12, accession 0001213900-20-006104.Report this figure7,212Total assets, FY2019, at 2019-12-31$7.2m. XBRL concept ifrs-full:Assets. 20-F/A filed 2021-05-19, accession 0001213900-21-027792.Report this figure6,503Total assets, FY2020, at 2020-12-31$6.5m. XBRL concept ifrs-full:Assets. 20-F filed 2022-03-30, accession 0001213900-22-016244.Report this figure6,618Total assets, FY2021, at 2021-12-31$6.6m. XBRL concept ifrs-full:Assets. 20-F filed 2023-03-22, accession 0001213900-23-021869.Report this figure4,186Total assets, FY2022, at 2022-12-31$4.2m. XBRL concept ifrs-full:Assets. 20-F filed 2023-03-22, accession 0001213900-23-021869.Report this figure2,426Total assets, period not labelled, at 2023-12-31$2.4m. XBRL concept ifrs-full:Assets. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figure5,842Total assets, period not labelled, at 2024-08-14$5.8m. XBRL concept ifrs-full:Assets. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figure8,550Total assets, FY2024, at 2024-12-31$8.6m. XBRL concept ifrs-full:Assets. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figure
Current liabilities$knot reportednot reported330Current liabilities, period not labelled, at 2016-12-31$330.0k. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2018-03-15, accession 0001213900-18-003028.Report this figure300Current liabilities, FY2017, at 2017-12-31$300.0k. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2018-03-15, accession 0001213900-18-003028.Report this figurenot reportednot reportednot reportednot reportednot reported206Current liabilities, period not labelled, at 2023-12-31$206.0k. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figurenot reported2,207Current liabilities, FY2024, at 2024-12-31$2.2m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figure
Total liabilities$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported5,842Total liabilities, period not labelled, at 2024-08-14$5.8m. XBRL concept ifrs-full:Liabilities. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figurenot reported
Shareholders' equity$k4,679Shareholders' equity, period not labelled, at 2014-12-31$4.7m. XBRL concept ifrs-full:Equity. 20-F filed 2018-03-15, accession 0001213900-18-003028.Report this figure4,887Shareholders' equity, period not labelled, at 2015-12-31$4.9m. XBRL concept ifrs-full:Equity. 20-F filed 2019-03-11, accession 0001213900-19-003911.Report this figure2,687Shareholders' equity, period not labelled, at 2016-12-31$2.7m. XBRL concept ifrs-full:Equity. 20-F filed 2020-03-12, accession 0001213900-20-006104.Report this figure3,619Shareholders' equity, FY2017, at 2017-12-31$3.6m. XBRL concept ifrs-full:Equity. 20-F/A filed 2021-05-19, accession 0001213900-21-027792.Report this figure7,273Shareholders' equity, FY2018, at 2018-12-31$7.3m. XBRL concept ifrs-full:Equity. 20-F filed 2022-03-30, accession 0001213900-22-016244.Report this figure6,515Shareholders' equity, FY2019, at 2019-12-31$6.5m. XBRL concept ifrs-full:Equity. 20-F filed 2023-03-22, accession 0001213900-23-021869.Report this figure3,612Shareholders' equity, FY2020, at 2020-12-31$3.6m. XBRL concept ifrs-full:Equity. 20-F filed 2023-03-22, accession 0001213900-23-021869.Report this figure5,333Shareholders' equity, FY2021, at 2021-12-31$5.3m. XBRL concept ifrs-full:Equity. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figure3,999Shareholders' equity, FY2022, at 2022-12-31$4.0m. XBRL concept ifrs-full:Equity. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figure2,220Shareholders' equity, period not labelled, at 2023-12-31$2.2m. XBRL concept ifrs-full:Equity. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figurenot reported5,435Shareholders' equity, FY2024, at 2024-12-31$5.4m. XBRL concept ifrs-full:Equity. 20-F filed 2025-04-30, accession 0001213900-25-037590.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. Listed shows no prices and gives no investment advice.